2024 Q3 Form 10-Q Financial Statement

#000121390024066676 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $4.043M $6.174M $71.00K
YoY Change 319.83% 8595.77%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.239M $8.910M $9.080M
YoY Change 77.86% -1.87% 301.41%
% of Gross Profit
Research & Development $2.000K
YoY Change -94.44%
% of Gross Profit
Depreciation & Amortization $27.00K $26.00K $20.00K
YoY Change -10.0% 30.0%
% of Gross Profit
Operating Expenses $7.239M $8.910M $9.082M
YoY Change 77.99% -1.89% 295.21%
Operating Profit -$3.196M -$2.736M -$9.011M
YoY Change 2.96% -69.64% 292.12%
Interest Expense -$586.0K -$2.642M $560.0K
YoY Change 33.18% -571.79% -120.15%
% of Operating Profit
Other Income/Expense, Net -$1.015M -$3.384M $348.0K
YoY Change 132.27% -1072.41% -112.52%
Pretax Income -$4.211M -$6.120M -$8.660M
YoY Change 18.95% -29.33% 70.57%
Income Tax
% Of Pretax Income
Net Earnings -$4.211M -$6.120M -$8.663M
YoY Change 18.92% -29.35% 70.63%
Net Earnings / Revenue -104.16% -99.13% -12201.41%
Basic Earnings Per Share -$0.67 -$1.01 -$1.79
Diluted Earnings Per Share -$0.67 -$1.01 -$1.79
COMMON SHARES
Basic Shares Outstanding 6.276M shares 5.935M shares 4.593M shares
Diluted Shares Outstanding 6.328M shares 6.063M shares 4.827M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.403M $12.12M $24.27M
YoY Change -54.49% -50.06% -40.18%
Cash & Equivalents $3.403M $5.802M $3.598M
Short-Term Investments $6.000M $6.320M $20.68M
Other Short-Term Assets $17.30M $15.68M $7.800M
YoY Change 119.01% 101.01% 3879.59%
Inventory
Prepaid Expenses
Receivables $285.0K $964.0K $6.300M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $24.76M $28.77M $38.42M
YoY Change -29.02% -25.13% -37.59%
LONG-TERM ASSETS
Property, Plant & Equipment $265.0K $291.0K $387.0K
YoY Change -26.59% -24.81%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $13.77M $15.29M $23.20M
YoY Change -39.33% -34.12% -8.94%
Other Assets $458.0K $458.0K $500.0K
YoY Change -8.4% -8.4% 222.58%
Total Long-Term Assets $18.67M $20.31M $29.27M
YoY Change -34.07% -30.63% 9.5%
TOTAL ASSETS
Total Short-Term Assets $24.76M $28.77M $38.42M
Total Long-Term Assets $18.67M $20.31M $29.27M
Total Assets $43.43M $49.07M $67.70M
YoY Change -31.29% -27.51% -23.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.293M $944.0K $200.0K
YoY Change 331.0% 372.0% 40.85%
Accrued Expenses $787.0K $2.499M $1.000M
YoY Change -34.42% 149.9% 45.56%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.416M $3.899M $2.658M
YoY Change 40.3% 46.69% 220.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.748M $2.815M $3.300M
YoY Change -11.35% -14.7%
Total Long-Term Liabilities $2.748M $2.815M $3.300M
YoY Change -11.35% -14.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.416M $3.899M $2.658M
Total Long-Term Liabilities $2.748M $2.815M $3.300M
Total Liabilities $5.164M $6.714M $5.917M
YoY Change 6.28% 13.47% 613.75%
SHAREHOLDERS EQUITY
Retained Earnings -$224.5M -$220.3M -$198.3M
YoY Change 11.24% 11.1% 15.04%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $501.0K $501.0K $501.0K
YoY Change 0.0% 0.0% -71.37%
Treasury Stock Shares
Shareholders Equity $38.27M $42.36M $61.78M
YoY Change
Total Liabilities & Shareholders Equity $43.43M $49.07M $67.70M
YoY Change -31.29% -27.51% -23.33%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$4.211M -$6.120M -$8.663M
YoY Change 18.92% -29.35% 70.63%
Depreciation, Depletion And Amortization $27.00K $26.00K $20.00K
YoY Change -10.0% 30.0%
Cash From Operating Activities -$4.717M $1.409M -$9.920M
YoY Change 31.76% -114.2% 387.23%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $60.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $2.318M $2.437M $4.040M
YoY Change -46.96% -39.68% -177.69%
Cash From Investing Activities $2.318M $2.437M $3.990M
YoY Change -46.83% -38.92% -176.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -4.717M 1.409M -9.920M
Cash From Investing Activities 2.318M 2.437M 3.990M
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -2.399M 3.846M -5.930M
YoY Change -407.56% -164.86% -81.38%
FREE CASH FLOW
Cash From Operating Activities -$4.717M $1.409M -$9.920M
Capital Expenditures $0.00 $60.00K
Free Cash Flow $1.409M -$9.980M
YoY Change -114.12% 390.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.92
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.45
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4827239 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5065055 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6029034 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6063003 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.79
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41845
dei Entity Registrant Name
EntityRegistrantName
DOMINARI HOLDINGS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-0849320
dei Entity Address Address Line1
EntityAddressAddressLine1
725 5th Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
22nd Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
dei City Area Code
CityAreaCode
(212)
dei Local Phone Number
LocalPhoneNumber
393-4540
dei Security12b Title
Security12bTitle
Common Stock ($0.0001 par value per share)
dei Trading Symbol
TradingSymbol
DOMH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6276138 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5802000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2833000 usd
CY2024Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
6320000 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
13547000 usd
CY2024Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
13365000 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
7687000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2314000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
898000 usd
CY2024Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
964000 usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
3177000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
28765000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
28142000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
291000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
344000 usd
CY2024Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1128000 usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1129000 usd
CY2024Q2 us-gaap Long Term Investments
LongTermInvestments
15285000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
24150000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3146000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3335000 usd
CY2024Q2 us-gaap Security Deposit
SecurityDeposit
458000 usd
CY2023Q4 us-gaap Security Deposit
SecurityDeposit
458000 usd
CY2024Q2 us-gaap Assets
Assets
49073000 usd
CY2023Q4 us-gaap Assets
Assets
57558000 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
944000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1036000 usd
CY2024Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
116000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
51000 usd
CY2024Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1954000 usd
CY2023Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
77000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
429000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
421000 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
456000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
22000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3899000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1607000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2815000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3028000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
6714000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
4635000 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6304183 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5995065 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6244035 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5934917 shares
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
263184000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
262187000 usd
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
60148 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
60148 shares
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
501000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
501000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-220324000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-208763000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
42359000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
52923000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49073000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57558000 usd
CY2024Q2 us-gaap Revenues
Revenues
6174000 usd
CY2023Q2 us-gaap Revenues
Revenues
71000 usd
us-gaap Revenues
Revenues
7541000 usd
us-gaap Revenues
Revenues
71000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8910000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9080000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13082000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12913000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
8910000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
9082000 usd
us-gaap Operating Expenses
OperatingExpenses
13081000 usd
us-gaap Operating Expenses
OperatingExpenses
12916000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2736000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9011000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5541000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-12845000 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
285000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
160000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
449000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
297000 usd
CY2024Q2 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
104000 usd
CY2023Q2 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
400000 usd
us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
678000 usd
us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
335000 usd
CY2024Q2 us-gaap Gain Loss On Sale Of Notes Receivable
GainLossOnSaleOfNotesReceivable
-742000 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Notes Receivable
GainLossOnSaleOfNotesReceivable
-212000 usd
us-gaap Gain Loss On Sale Of Notes Receivable
GainLossOnSaleOfNotesReceivable
-1657000 usd
us-gaap Gain Loss On Sale Of Notes Receivable
GainLossOnSaleOfNotesReceivable
-212000 usd
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3031000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5490000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3384000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
348000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6020000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
420000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-6120000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-8663000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11561000 usd
us-gaap Net Income Loss
NetIncomeLoss
-12425000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.79
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.92
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.45
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6063003 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4827239 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6029034 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5065055 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
47669000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
810000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-6120000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
42359000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
69071000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1370000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-8663000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
61778000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
52923000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
997000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11561000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
42359000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
73767000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1375000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
939000 usd
us-gaap Net Income Loss
NetIncomeLoss
-12425000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
61778000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11561000 usd
us-gaap Net Income Loss
NetIncomeLoss
-12425000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
189000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
182000 usd
us-gaap Depreciation
Depreciation
52000 usd
us-gaap Depreciation
Depreciation
32000 usd
domh Change In Fair Value Of Longterm Investment
ChangeInFairValueOfLongtermInvestment
5490000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
997000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2675000 usd
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
3330000 usd
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
-487000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-2940000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
514000 usd
us-gaap Gain Loss On Sale Of Notes Receivable
GainLossOnSaleOfNotesReceivable
-1657000 usd
us-gaap Gain Loss On Sale Of Notes Receivable
GainLossOnSaleOfNotesReceivable
-212000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
78000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
229000 usd
domh Increase Decrease In Prepaid Acquisition Cost
IncreaseDecreaseInPrepaidAcquisitionCost
-301000 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
5678000 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
3532000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-92000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-428000 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
65000 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-628000 usd
domh Increase Decrease In Accrued Commissions
IncreaseDecreaseInAccruedCommissions
1877000 usd
domh Increase Decrease In Accrued Commissions
IncreaseDecreaseInAccruedCommissions
-8000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-205000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
58000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
434000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
3000 usd
us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
-58000 usd
us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
99000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7185000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13913000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3963000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
34014000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
11580000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
20494000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
419000 usd
domh Acquisition Of Fps Net Of Cash Acquired And Receivable Owed From Fps
AcquisitionOfFPSNetOfCashAcquiredAndReceivableOwedFromFPS
1112000 usd
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
500000 usd
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
502000 usd
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
1340000 usd
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
100000 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
125000 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
75000 usd
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
3500000 usd
domh Proceedsfrom Collectionof Loans To Employees
ProceedsfromCollectionofLoansToEmployees
2000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10154000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14724000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
939000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-939000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2969000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-29576000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2833000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33174000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5802000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3598000 usd
CY2022Q4 domh Investments Company Fee Paid Indirectly
InvestmentsCompanyFeePaidIndirectly
2000000 usd
us-gaap Investment Company Fee Paid Indirectly
InvestmentCompanyFeePaidIndirectly
1400000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include stock-based compensation, the valuation of investments, the valuation of notes receivable and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</span></p>
CY2024Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
13400000 usd
CY2024Q2 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
2360000 usd
CY2023Q2 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-432000 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
3330000 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-487000 usd
CY2024Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-2353000 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
643000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-2940000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
514000 usd
CY2024Q2 us-gaap Investment Income Dividend
InvestmentIncomeDividend
97000 usd
CY2023Q2 us-gaap Investment Income Dividend
InvestmentIncomeDividend
189000 usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
288000 usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
308000 usd
CY2024Q2 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
104000 usd
CY2023Q2 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
400000 usd
us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
678000 usd
us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
335000 usd
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
20922000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
24150000 usd
CY2024Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
17547000 usd
CY2024Q2 us-gaap Long Term Investments
LongTermInvestments
15285000 usd
CY2024Q2 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
3000000 usd
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
5500000 usd
CY2024Q1 domh Public Offering Price
PublicOfferingPrice
4
CY2024Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.3
CY2023 us-gaap Investment Company Committed Capital
InvestmentCompanyCommittedCapital
2800000 usd
us-gaap Investment Company Committed Capital
InvestmentCompanyCommittedCapital
0 usd
us-gaap Interest Income Other
InterestIncomeOther
100000 usd
CY2024Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
6320000 usd
CY2024Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
6320000 usd
CY2024Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
964000 usd
CY2024Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1128000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
13547000 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
13547000 usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
3177000 usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1129000 usd
us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
1700000 usd
us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
1700000 usd
CY2024Q2 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
700000 usd
CY2024Q2 us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
700000 usd
CY2022Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P7Y
CY2023Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
12874 usd
us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
13502 usd
CY2022Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P7Y
CY2022Q3 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
49368 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
51868 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3146000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
429000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2815000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3244000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10 pure
CY2023Q2 us-gaap Lease Cost
LeaseCost
6000000 usd
CY2024Q2 us-gaap Lease Cost
LeaseCost
200000 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
178000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
356000 usd
CY2024Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
178000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
356000 usd
CY2024Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
23000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
45000 usd
CY2024Q2 domh Operating Lease Rent Expense Net
OperatingLeaseRentExpenseNet
201000 usd
domh Operating Lease Rent Expense Net
OperatingLeaseRentExpenseNet
401000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
179000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
313000 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
179000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
313000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
33000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
63000 usd
CY2023Q2 domh Operating Lease Rent Expense Net
OperatingLeaseRentExpenseNet
212000 usd
domh Operating Lease Rent Expense Net
OperatingLeaseRentExpenseNet
376000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
374000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
373000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
685000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
685000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
685000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
766000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1160000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4354000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1110000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3244000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
969096 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
476023 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6304183 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6244035 shares
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
60148 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
700000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
200000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
420168 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.8
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y3M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
108 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
5161.54
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
420060 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.48
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M18D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
132439 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
6.77
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P8Y6M
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5000000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
400000 usd
CY2024Q2 us-gaap Revenues
Revenues
6174000 usd
CY2023Q2 us-gaap Revenues
Revenues
71000 usd
us-gaap Revenues
Revenues
7541000 usd
us-gaap Revenues
Revenues
71000 usd
CY2024Q2 domh Net Capital Amount
NetCapitalAmount
12600000 usd
CY2024Q2 us-gaap Excess Capital
ExcessCapital
12400000 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
80000000 usd
CY2024Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0 usd
CY2023Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
80000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
domh Stock Issued During Period Value Cancellation Of Common Stock
StockIssuedDuringPeriodValueCancellationOfCommonStock
usd
us-gaap Treasury Stock Retired Par Value Method Amount
TreasuryStockRetiredParValueMethodAmount
usd
domh Change In Fair Value Of Longterm Investment
ChangeInFairValueOfLongtermInvestment
usd
domh Increase Decrease In Prepaid Acquisition Cost
IncreaseDecreaseInPrepaidAcquisitionCost
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
domh Acquisition Of Fps Net Of Cash Acquired And Receivable Owed From Fps
AcquisitionOfFPSNetOfCashAcquiredAndReceivableOwedFromFPS
usd
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
usd
domh Proceedsfrom Collectionof Loans To Employees
ProceedsfromCollectionofLoansToEmployees
usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
usd
domh Employee Options Expired Weighted Average Remaining Contractual Life
EmployeeOptionsExpiredWeightedAverageRemainingContractualLife
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000012239

Files In Submission

Name View Source Status
0001213900-24-066676-index-headers.html Edgar Link pending
0001213900-24-066676-index.html Edgar Link pending
0001213900-24-066676.txt Edgar Link pending
0001213900-24-066676-xbrl.zip Edgar Link pending
domh-20240630.xsd Edgar Link pending
ea0210152-10q_dominari.htm Edgar Link pending
ea021015201ex31-1_dominari.htm Edgar Link pending
ea021015201ex31-2_dominari.htm Edgar Link pending
ea021015201ex32-1_dominari.htm Edgar Link pending
ea021015201ex32-2_dominari.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
domh-20240630_def.xml Edgar Link unprocessable
domh-20240630_lab.xml Edgar Link unprocessable
domh-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ea0210152-10q_dominari_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
domh-20240630_cal.xml Edgar Link unprocessable